Skip to main content
ACS AuthorChoice logoLink to ACS AuthorChoice
. 2026 Mar 24;28(13):4020–4025. doi: 10.1021/acs.orglett.6c00477

Net Oxidative Photocatalytic Strategy toward the o‑Trifluoroacetylation of N‑Heteroarenes

Kyra L Samony 1, Jabez Z Thullaprambil 1, Rifat N Nabi 1, Kyle E Brunner 1, Daniel K Kim 1,*
PMCID: PMC13054869  PMID: 41875314

Abstract

The direct introduction of fluorinated functional groups into small molecules remains one of the most powerful chemical transformations toward synthesizing biologically active compounds. Heteroaromatics are particularly significant scaffolds, and fluorofunctionalization reactions are still in demand. Herein, we report a protocol to synthesize heteroaromatic trifluoromethyl ketones (TFMKs), installed through photomediated Minisci coupling, followed by subsequent deketalization. We have demonstrated the key Minisci reaction in more than 10 unique heterocyclic classes, notably including pyridines, pyrazines, pyridazines, pyrimidines, quinolines, and polycyclic systems, alongside select deketalizations of high-value aromatics.


graphic file with name ol6c00477_0007.jpg


graphic file with name ol6c00477_0006.jpg


N-Heteroarenes are some of the most frequently represented scaffolds in chemistry, appearing often in both natural products and synthetic medicines. Aromatic N-heterocycles such as pyridines, diazines, and quinolines are of particular interest to synthetic chemists as they have been recognized as the most prevalent heterocyclic scaffolds among FDA-approved compounds in the past decade (Figure A). Functionalization protocols for these electron-deficient heteroarenes are well-studied, with the Minisci reaction remaining one of the most powerful tools for accessing medicinally viable heterocyclic candidates.

1.

1

Importance and challenges of trifluoroacetylation of heteroaromatics through Minisci functionalization.

Alongside evaluating heterocycles, , the introduction of fluorine atoms has also become a prominent strategy in synthesizing therapeutic lead compounds. Considering the prevalence of both functional groups, the incorporation of fluorinated motifs into heterocycles is an extremely desirable transformation. Trifluoromethyl ketones (TFMKs) are of particular interest for their roles as enzymatic inhibitors, as they can act as electrophilic warheads through reversible covalent bonds (Figure B). − Additionally, TFMKs are known to be employed as building blocks toward fluorinated heterocycles and as functional group substitutes for carboxylic acids. −

Minisci reactions are driven by the addition of electron-rich, carbon-centered radicals into electron-deficient, heteroaromatic rings. As such, the direct installation of TFMKs is challenging due to the inherent polarity mismatch of the electron-poor trifluoromethylacyl radical (Figure C). We propose that we can overcome this polarity mismatch by employing a nucleophilic radical. Our previously reported masked acetylating reagent yields a fluorinated acetal radical, which would enable the necessary reactivity parameters for Minisci coupling.

Others have demonstrated addition of the masked ketone into select heterocyclic classes of quinoxalinones, , quinolines, and azauracils (Figure D). These examples are powerful precedents for the functionalization of specific heterocyclic classes. However, these protocols do not address more common heterocyclic scaffolds in medicinal chemistry, such as pyridines and diazines. Herein, we developed a net oxidative approach toward the trifluoroacetylation of heteroaromatics, first through photomediated C–H functionalization, followed by deketalization to yield the desired N-heterocyclic TFMK (Figure E).

Our seminal work focused on the design of masked acyl reagents to install TFMKs into electron-deficient olefins in a redox-neutral approach. In contrast, a Minisci-type reaction necessitates a net oxidative protocol for the incorporation of masked TFMKs into heterocycles by using our proposed reagent design (Table ). We selected 4-(trifluoromethyl)­pyridine as our model substrate and evaluated a variety of differentially modified TFMK precursors (1-CO 2 H–4-CO 2 H) to study both reactivity and deketalization. As expected and in agreement with our previous study, no desired product was observed in the reaction with trifluoropyruvic acid 1-CO 2 H (entry 1). In our prior work, N,O-acetals were used as an alternative to the dioxolane scaffold as these could be readily deketalized with aqueous HCl. However, when we began our initial screenings, to our surprise, the use of N,O-acetal reagent 2-CO 2 Na was unsuccessful (entry 2) and resulted in no desired product, even with the addition of an acid activator (entry 3). Acylated oxazolidine derivative 3-CO 2 H was also unsuccessful (entry 4). With the optimized conditions of photocatalyst (Ir­[dF­(CF3)­ppy]2(dtbbpy))­PF6 and oxidant (NH4)2S2O8 in a 1:1 solvent mixture of DMSO and water irradiated with 34 W Kessil 456 nm LEDs for 18 h, we obtained the best reactivity using O,O-acetal 4-CO 2 H (77% isolated yield, entry 5). It can be noted that while organophotocatalyst 4CzIPN gave similar results, we opted to move forward with the iridium photocatalyst for ease of purification.

1. TFMK Reagent Screen and Corresponding Results.

graphic file with name ol6c00477_0005.jpg

entry conditions yield (%)
1 1-CO2H instead of 4-CO2H 0
2 2-CO2Na instead of 4-CO2H 0
3 entry 2 with 3.0 equiv of H2SO4 0
4 3-CO2H instead of 4-CO2H 0
5 as shown 90 (77)
a

Yields determined by 19F NMR using trifluorotoluene as an internal standard. The yield in parentheses is the isolated yield after flash column chromatography. See the Supporting Information for additional reaction optimization.

To further understand our experimental outcomes, we used computational methods to evaluate the corresponding electrophilicity indices (ω) of the radicals derived from compounds 1-CO 2 H–4-CO 2 H (Figure ). , The values of the radicals from reagents 1-CO 2 H and 4-CO 2 H had been previously reported, and our calculated polarities for 1 • and 4 • were consistent with the literature, calculated as 1.71 and 0.97 eV, respectively. These values serve both to reinforce the mismatched polarity of 1 • toward electron-poor partners and to quantify the required nucleophilicity of 4 • that ensures excellent reactivity. We found the value of radical 3 •, from acylated N,O-derivative 3-CO 2 H, to be 1.31 eV, which appears to be too electrophilic for addition to N-heterocycles. Radical 2 • derived from reagent 2-CO 2 Na was determined to have a value of 0.80 eV, confirming enhanced nucleophilicity compared to model O,O-acetal derivative 4 •. Considering that radical 2 • is the most nucleophilic of all radicals and had previous success in coupling to electron-deficient olefins, we hypothesized that our contradictory results were due to differences in reaction conditions compared to our initial study. Our optimal conditions include the use of persulfate that decomposes to the sulfate radical anion (SO4 –•), which is known to possess exceptional single-electron oxidizing power (∼2.25–2.85 V vs SCE). It is known that the more nucleophilic a radical, the more easily oxidized it is to a stabilized carbocation. We propose that this is true in the case of our N,O-acetal reagent. Under oxidative conditions, α-amino radical 2 • rapidly oxidizes to carbocation 2 + , which yields the fluorinated dihydrooxazole species upon deprotonation (Figure ). We were able to experimentally confirm the presence of 2-(trifluoromethyl)-4,5-dihydrooxazole through both independent synthesis and NMR studies under DMSO-only solvent conditions. We anticipated that this dihydrooxazole would be hydrolyzed under the standard aqueous solvent conditions and were able to confirm that we had indeed generated trifluoroacetic acid (TFA) as a major fluorinated byproduct (see the Supporting Information for further details). We believe that these data are key evidence of carbocation formation and further confirm that the use of reagent 2-CO 2 Na is not feasible under oxidizing conditions.

2.

2

Electrophilicity indices (ω) of masked radicals and plausible oxidative decomposition pathway.

Following the conclusion of our optimization studies, we went forward with highest-yielding masked reagent 4-CO 2 H as our TFMK precursor and demonstrated the success of our reaction conditions on a wide scope of heterocycles (Figure ). While our iridium-based photocatalyst conditions worked well for a majority of our substrate scope (Figure , condition A), we found that some extended heteroaromatics demonstrated increased reactivity when subjected to photomediated hypervalent iodine conditions (Figure , condition B) using (bis­(trifluoroacetoxy)­iodo)­benzene (PIFA). With our optimized conditions in hand, we were able to showcase our method on a variety of 4-, 3-, and 2-substituted and electronically diverse pyridines in 13–79% yields (5–12). Notably, functionalization of biologically active (−)-nicotine was showcased in 60% yield with only one regioisomer (9). In the case of 3-phenylpyridine, we were able to successfully isolate the Minisci product as a single regioisomer (10), with a crystal structure confirming regioselectivity at sterically favored position 6 (see the Supporting Information for the crystal structure).

3.

3

Substrate scope of masked heterocycles. See the Supporting Information for experimental details.

Excitingly, we were able to highlight the coupling of our masked acyl reagent to a wide scope of coveted diazine heterocycles, such as pyrimidines and pyridazines. Fluorofunctionalizations (13–15) of ethyl pyrimidine-5-carboxylate, 4-phenylpyrimidine, and 4,6-dimethylpyrimidine were demonstrated in 44%, 45%, and 78% yields, respectively. Installation of the masked TFMK on 4-methylpyridazine was achieved in an excellent 91% yield (16), with decorated pyridazines 3,6-dichloropyridazine-4-carbonitrile and methyl 6-chloropyridazine-4-carboxylate being accessed in modest yields of 52% (17) and 25% (18), respectively. To probe the extent of our methodology, we screened a variety of extended azole-fused pyridazines, achieving 60% yields for both decorated imidazo­[1,2-b]­pyridazines (19 and 21). We were also successful in the fluorofunctionalization of triazolo­[4,3-b]­pyridazine accessed in a modest 40% yield (20).

Further screening revealed success with quinolines and isoquinolines, both recognized as traditional Minisci coupling partners. We obtained an isolated 63% yield of functionalized 4-methylquinoline (22), a common model substrate for such reactions. We were also able to install our TFMK precursor on 4-chloroisoquinoline and ethyl isoquinoline-3-carboxylate in 42% yield (23) and 54% yield (24), respectively. As our method works exceptionally well for pyrimidines and pyridazines, we were also able to showcase fully substituted pyrazine in 28% yield (25). We achieved a 62% yield (26) of benzylated quinoxalin-2­(1H)-one and a 67% yield (27) of unsubstituted quinazoline. We were also able to achieve an exemplary 92% coupling yield (28) by employing benzothiazole, a traditionally accessible Minisci reagent. Constitutional isomers, phenanthridine and acridine, were functionalized in 83% (29) and 46% (30) yields, respectively. Overall, we were able to install our masked TFMK reagent into a large and diverse scope of N-heterocycles, representing more than 10 heterocyclic classes.

With our trifluoromethylketalization scope in hand, we were excited to showcase select deketalizations to the highly desired trifluoromethyl ketones. Unlike 1,3-dioxolane, the trifluoroketal motif is extremely stable and does not decompose under traditional acidic conditions. , Our understanding of the nature of the enhanced stability of trifluoromethyl ketals is reinforced by our synthesis of 4-CO 2 H, which necessitates the use of bromoethanol rather than traditional ethylene glycol for its formation. With this insight in hand, we postulated that the deprotection should also proceed through a microscopic reverse reaction to yield a bromoethanol-like byproduct. On this premise, we proposed the use of BBr3 to be the most reasonable reagent to use for the general deketalization protocol (Figure ). After many trials, we found that rigorously dried, oxygen-free conditions were necessary for continued success and reproducibility. The reactions were performed inside of a glovebox using neat boron tribromide, followed by an aqueous quench outside of the glovebox.

4.

4

Substrate scope of unmasked heterocycles and proposed deketalization steps. Thermal ellipsoids are shown at the 50% probability level.

With these conditions in hand, we were able to access hydrated TFMK pyridine and pyrimidine derivatives 31-H 2 O and 32-H 2 O in 69% and 42% yields, respectively. The deketalization of benzothiazole derivative 28 was executed in an exciting 92% yield (33-H 2 O). In agreement with previous reports, we obtained a crystal structure of 33-H 2 O that confirms hydrated TFMK. Finally, phenanthridine-coupled product 29 was unmasked to afford hydrated product 34-H 2 O in 38% yield. Interestingly, during our deketalization study with substrate 29, we observed a new species in the crude reaction mixture that did not correspond to the final product. From the crude reaction, we were able to fully and unambiguously characterize this new species by crystal structure as hemiacetal complex 29-BBr 3 -int. Excitingly, this intermediate contains a bromoethanol motif, again supporting the unusual stability of fluorinated hemiacetals and our microscopic proposal for ease of deketalization.

Based on our observations, we believe that after the addition of boron tribromide boron will form a complex with the starting material to yield proposed intermediate 29-BBr 3 . This intermediate can rearrange to form stabilized hemiacetal 29-BBr 3 -int, which progresses to final product 34-H 2 O after silica gel workup. The isolation and identification of this stable boron intermediate were key in understanding the challenges associated with deketalizations on nitrogen-containing scaffolds.

In conclusion, we have developed a method to synthesize N-heterocyclic trifluoromethyl ketones (TFMKs) by employing our masked acyl radical reagent. We harnessed photoredox catalysis to install our TFMK precursor into more than 20 substrates encompassing more than 10 heterocyclic classes, including pyridines and diazines. We have also elucidated the potential intermediates in the Lewis acid-mediated deketalization of our trifluoromethylketal masking group. We are excited to provide the greater synthetic community with a general method to install TFMKs into biologically relevant small molecule heterocyclic scaffolds.

Supplementary Material

ol6c00477_si_001.pdf (5.6MB, pdf)
ol6c00477_si_002.xlsx (14.6KB, xlsx)

Acknowledgments

Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Grant 1R35GM154965. The authors gratefully acknowledge the research support from the College of Science and Technology, Temple University. K.L.S. is partially supported by the Future Faculty Assistantship from the College of Science and Technology at Temple University. The authors thank Dr. Xiaoli (Shelly) Gao of the Mass Spectrometry Facility at the Department of Chemistry at the University of Pennsylvania for assistance with accurate mass measurement (AMM) data acquisition. The authors also thank Dr. Beth Moscato for maintaining the NMR facilities at Temple University and assisting in obtaining spectra. Finally, the authors thank Dr. Michael J. Zdilla for his guidance with the X-ray Facility at Temple University. Single-crystal X-ray diffraction is supported by a Major Research Instrumentation grant from the National Science Foundation under Grant CHE-2215854.

The data underlying this study are available in the published article and its .

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.orglett.6c00477.

  • Experimental procedures, characterization data, HRMS, XRD data, and 1H, 13C, and 19F nuclear magnetic resonance spectra of all compounds (PDF)

  • Radical polarity computational data (XLSX)

The authors declare no competing financial interest.

References

  1. Katritzky A. R.. Introduction: Heterocycles. Chem. Rev. 2004;104:2125. doi: 10.1021/cr0406413. [DOI] [Google Scholar]
  2. Heravi M. M., Zadsirjan V.. Prescribed Drugs Containing Nitrogen Heterocycles: An Overview. RSC Adv. 2020;10(72):44247–44311. doi: 10.1039/D0RA09198G. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Marshall C. M., Federice J. G., Bell C. N., Cox P. B., Njardarson J. T.. An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023) J. Med. Chem. 2024;67:11622. doi: 10.1021/acs.jmedchem.4c01122. [DOI] [PubMed] [Google Scholar]
  4. Duncton M. A. J.. Minisci Reactions: Versatile CH-Functionalizations for Medicinal Chemists. MedChemComm. 2011;2:1135. doi: 10.1039/c1md00134e. [DOI] [Google Scholar]
  5. Meanwell N. A.. The Influence of Bioisosteres in Drug Design: Tactical Applications to Address Developability Problems. Top. Med. Chem. 2013;9:283. doi: 10.1007/7355_2013_29. [DOI] [Google Scholar]
  6. Ward M., O’Boyle N. M.. Analysis of the Structural Diversity of Heterocycles amongst European Medicines Agency Approved Pharmaceuticals (2014–2023) RSC Med. Chem. 2025;16:4540. doi: 10.1039/D5MD00403A. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gillis E. P., Eastman K. J., Hill M. D., Donnelly D. J., Meanwell N. A.. Applications of Fluorine in Medicinal Chemistry. J. Med. Chem. 2015;58(21):8315. doi: 10.1021/acs.jmedchem.5b00258. [DOI] [PubMed] [Google Scholar]
  8. Rizzo C., Amata S., Pibiri I., Pace A., Buscemi S., Palumbo Piccionello A.. FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022. Int. J. Mol. Sci. 2023;24:7728. doi: 10.3390/ijms24097728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gelb M. H., Svaren J. P., Abeles R. H.. Fluoro Ketone Inhibitors of Hydrolytic Enzymes. Biochemistry. 1985;24(8):1813. doi: 10.1021/bi00329a001. [DOI] [PubMed] [Google Scholar]
  10. Sydnes M. O., Hayashi Y., Sharma V. K., Hamada T., Bacha U., Barrila J., Freire E., Kiso Y.. Synthesis of Glutamic Acid and Glutamine Peptides Possessing a Trifluoromethyl Ketone Group as SARS-CoV 3CL Protease Inhibitors. Tetrahedron. 2006;62(36):8601. doi: 10.1016/j.tet.2006.06.052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Zhang Z., Wang Y., Chen X., Song X., Tu Z., Chen Y., Zhang Z., Ding K.. Characterization of an Aromatic Trifluoromethyl Ketone as a New Warhead for Covalently Reversible Kinase Inhibitor Design. Bioorg. Med. Chem. 2021;50:116457. doi: 10.1016/j.bmc.2021.116457. [DOI] [PubMed] [Google Scholar]
  12. Camerino E., Wong D. M., Tong F., Körber F., Gross A. D., Islam R., Viayna E., Mutunga J. M., Li J., Totrov M. M., Bloomquist J. R., Carlier P. R.. Difluoromethyl Ketones: Potent Inhibitors of Wild Type and Carbamate-Insensitive G119S Mutant Anopheles Gambiae Acetylcholinesterase. Bioorg. Med. Chem. Lett. 2015;25(20):4405. doi: 10.1016/j.bmcl.2015.09.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Six-Membered Heterocycle Substituted Trifluoroethanone Derivatives As Histone Deacetylase (HDAC) Inhibitors. WO2007107594A2, 2007.
  14. Liu Y., Tian Q., Ge J., Wu X., Li Z., Cheng G.. Recent Advances in the Synthesis of Trifluoromethyl-Containing Heterocyclic Compounds via Trifluoromethyl Building Blocks. Org. Biomol. Chem. 2024;22:6246. doi: 10.1039/D4OB00877D. [DOI] [PubMed] [Google Scholar]
  15. Bredael K., Geurs S., Clarisse D., De Bosscher K., D’hooghe M.. Carboxylic Acid Bioisosteres in Medicinal Chemistry: Synthesis and Properties. J. Chem. 2022;2022:2164558. doi: 10.1155/2022/2164558. [DOI] [Google Scholar]
  16. Ballatore C., Huryn D. M., Smith A. B.. Carboxylic Acid (Bio)­Isosteres in Drug Design. ChemMedChem. 2013;8(3):385. doi: 10.1002/cmdc.201200585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lassalas P., Gay B., Lasfargeas C., James M. J., Tran V., Vijayendran K. G., Brunden K. R., Kozlowski M. C., Thomas C. J., Smith A. B. I. I. I., Huryn D. M., Ballatore C.. Structure Property Relationships of Carboxylic Acid Isosteres. J. Med. Chem. 2016;59(7):3183–3203. doi: 10.1021/acs.jmedchem.5b01963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Proctor R. S. J., Phipps R. J.. Recent Advances in Minisci-Type Reactions. Angew. Chem., Int. Ed. 2019;58:13666. doi: 10.1002/anie.201900977. [DOI] [PubMed] [Google Scholar]
  19. Han S., Samony K. L., Nabi R. N., Bache C. A., Kim D. K.. Hydrotrifluoroacetylation of Alkenes via Designer Masked Acyl Reagents. J. Am. Chem. Soc. 2023;145(21):11530–11536. doi: 10.1021/jacs.3c04294. [DOI] [PubMed] [Google Scholar]
  20. Ye Z.-P., Guo M., Ye Y.-Q., Yuan C.-P., Wang H.-L., Yang J.-S., Chen H.-B., Xiang H.-Y., Chen K., Yang H.. Iodine­(III)-Mediated Trifluoroacetylation of a C­(Sp2)–H or C­(Sp)–H Bond with Masked Trifluoroacyl Reagents. Org. Lett. 2024;26(24):5196–5201. doi: 10.1021/acs.orglett.4c01780. [DOI] [PubMed] [Google Scholar]
  21. Gao S., Huang Y., Cai M., Liu X., Jiang D., Wang X., Dai L.. Trifluoroacetylation of C­(Sp2)–H Bonds Using Masked Trifluoroacyl Reagents: Photoinitiated (Photosensitiser-Free) vs. Thermal. Mol. Catal. 2026;589:115620. doi: 10.1016/j.mcat.2025.115620. [DOI] [Google Scholar]
  22. Shen Y., Li Y., Wang X., Wei J., Shen Y., Wu L., Luo K.. Late-Stage C–H Trifluoroacetylation of Quinoxaline-2­(1H)-Ones Using Masked Trifluoroacyl Reagents. Org. Biomol. Chem. 2025;23(7):1683–1688. doi: 10.1039/D4OB01945H. [DOI] [PubMed] [Google Scholar]
  23. An J., Chen X., Zhuang Y., Xiang P., Sun K., Chen X., Liu P., Qu L., Yu B.. Visible-Light-Driven Trifluoroacetylation of Azauracils. J. Org. Chem. 2025;90(32):11486. doi: 10.1021/acs.joc.5c00987. [DOI] [PubMed] [Google Scholar]
  24. Garwood J. J. A., Chen A. D., Nagib D. A.. Radical Polarity. J. Am. Chem. Soc. 2024;146(41):28034–28059. doi: 10.1021/jacs.4c06774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. De Vleeschouwer F., Van Speybroeck V., Waroquier M., Geerlings P., De Proft F.. Electrophilicity and Nucleophilicity Index for Radicals. Org. Lett. 2007;9(14):2721. doi: 10.1021/ol071038k. [DOI] [PubMed] [Google Scholar]
  26. Fernandes A. J., Giri R., Houk K. N., Katayev D.. Review and Theoretical Analysis of Fluorinated Radicals in Direct CAr–H Functionalization of (Hetero)­Arenes. Angew. Chem., Int. Ed. 2024;63(16):e202318377. doi: 10.1002/anie.202318377. [DOI] [PubMed] [Google Scholar]
  27. Dong J., Wang Z., Wang X., Song H., Liu Y., Wang Q.. Metal-, Photocatalyst-, and Light-Free Minisci C-H Alkylation of N-Heteroarenes with Oxalates. J. Org. Chem. 2019;84(11):7532. doi: 10.1021/acs.joc.9b00972. [DOI] [PubMed] [Google Scholar]
  28. Neta P., Huie R. E., Ross A. B.. Rate Constants for Reactions of Inorganic Radicals in Aqueous Solution. J. Phys. Chem. Ref. Data. 1988;17(3):1027. doi: 10.1063/1.555808. [DOI] [Google Scholar]
  29. Genovino J., Lian Y., Zhang Y., Hope T. O., Juneau A., Gagné Y., Ingle G., Frenette M.. Metal-Free-Visible Light C-H Alkylation of Heteroaromatics via Hypervalent Iodine-Promoted Decarboxylation. Org. Lett. 2018;20(11):3229. doi: 10.1021/acs.orglett.8b01085. [DOI] [PubMed] [Google Scholar]
  30. Guthrie J. P.. Carbonyl Addition Reactions: Factors Affecting the Hydrate–Hemiacetal and Hemiacetal–Acetal Equilibrium Constants. Can. J. Chem. 1975;53(6):898. doi: 10.1139/v75-125. [DOI] [Google Scholar]
  31. Kelly C. B., Mercadante M. A., Leadbeater N. E.. Trifluoromethyl Ketones: Properties, Preparation, and Application. Chem. Commun. 2013;49(95):11133. doi: 10.1039/c3cc46266h. [DOI] [PubMed] [Google Scholar]
  32. Berlin C. B., Sidlow E., Zheng C., Kozlowski M. C.. Quantification of the H-Bond-Donating Ability of Trifluoromethyl Ketone Hydrates Using a Colorimetric Sensor. J. Org. Chem. 2025;90(21):7120. doi: 10.1021/acs.joc.4c03046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Khodakovskiy P. V., Volochnyuk D. M., Panov D. M., Pervak I. I., Zarudnitskii E. V., Shishkin O. V., Yurchenko A. A., Shivanyuk A., Tolmachev A. A.. 2-(Trifluoroacetyl)­Imidazoles, 2-Trifluoroacetyl-1,3-Thiazoles, and 2-Trifluoroacetyl-1,3-Oxazoles. Synthesis. 2008;2008:948. doi: 10.1055/s-2008-1032197. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ol6c00477_si_001.pdf (5.6MB, pdf)
ol6c00477_si_002.xlsx (14.6KB, xlsx)

Data Availability Statement

The data underlying this study are available in the published article and its .


Articles from Organic Letters are provided here courtesy of American Chemical Society

RESOURCES